Full metadata record
DC FieldValueLanguage
dc.creatorVives, M. (Marc)-
dc.creatorMonedero, P. (Pablo)-
dc.creatorPerez-Valdivieso, J.R. (José Ramón)-
dc.creatorGarcia-Fernandez, N. (Nuria)-
dc.creatorLavilla, J. (Javier)-
dc.creatorHerreros, J. (Jesús)-
dc.creatorBes-Rastrollo, M. (Maira)-
dc.date.accessioned2024-02-09T11:46:41Z-
dc.date.available2024-02-09T11:46:41Z-
dc.date.issued2011-
dc.identifier.citationVives, M. (Marc); Monedero, P. (Pablo); Perez-Valdivieso, J.R. (José Ramón); et al. "External validation and comparison of three scores to predict renal replacement therapy after cardiac surgery: A multicenter cohort". The International Journal of Artificial Organs. 34 (4), 2011, 329 - 338es
dc.identifier.issn0391-3988-
dc.identifier.urihttps://hdl.handle.net/10171/68980-
dc.description.abstractPurpose: Cardiac surgery-associated acute kidney injury requiring renal replacement therapy (RRT) is independently associated with mortality. Several risk scores have been developed to predict the need for RRT after cardiac surgery. We have compared and verified the external validity of the three main available scores for RRT prediction after cardiac surgery: the Thakar score, the Mehta tool, and the Simplified Renal Index. Methods: The risk scores were calculated in a cohort of 1084 adult patients, 248 of whom required RRT, who underwent open-heart surgery in 24 Spanish hospitals in 2007. The performance of the systems was determined by examining their discrimination (areas under the receiver operating characteristic curves (aROC) and calibration (Lemeshow-Hosmer chi-square goodness-of-fit statistics). Results: The aROCs in the Thakar score, the Mehta tool, and the Simplified Renal Index were 0.82, 0.76 and 0.79, respectively. The three scoring systems were poorly calibrated and tended to underestimate the actual need for RRT. Conclusions: The Thakar score and the Simplified Renal Index discriminated well between low - and high-risk patients in our cohort, and Thakar outperformed the Mehta tool. These best-performing scores may aid in the selection of optimal therapy, facilitate the planning of hospital resource utilization, improve preoperative counseling, select participants for clinical trials of renal-protective therapies and enable an accurate comparison between different institutions or surgeons.es_ES
dc.language.isoenges_ES
dc.publisherSAGE Publicationses_ES
dc.rightsinfo:eu-repo/semantics/closedAccesses_ES
dc.subjectCardiac Surgical Procedures/adverse effectses_ES
dc.subjectKidney Failure - Acute/diagnosises_ES
dc.subjectKidney Failure - Acute/etiologyes_ES
dc.subjectKidney Failure - Acute/therapy,es_ES
dc.subjectRenal Replacement Therapyes_ES
dc.subjectValidation studieses_ES
dc.titleExternal validation and comparison of three scores to predict renal replacement therapy after cardiac surgery: A multicenter cohortes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.5301/IJAO.2011.7728-
dadun.citation.endingPage338es_ES
dadun.citation.number4es_ES
dadun.citation.publicationNameThe International Journal of Artificial Organses_ES
dadun.citation.startingPage329es_ES
dadun.citation.volume34es_ES

Files in This Item:
File
vives-et-al-2011-external-validation-and-comparison-of-three-scores-to-predict-renal-replacement-therapy-after-cardiac.pdf
Description
Size
101.12 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.